Pyrrole-based EGFR inhibitors for the treatment of NCSLC: Binding modes and SARs investigations

被引:6
作者
He, Jie [1 ]
Luo, Leixuan [1 ]
Xu, Shidi [1 ]
Yang, Feiyi [1 ]
Zhu, Wufu [1 ]
机构
[1] Jiangxi Sci & Technol Normal Univ, Sch Pharm, Jiangxi Prov Key Lab Drug Design & Evaluat, Nanchang, Jiangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
activity; molecular docking study; NSCLC; pyrrole; SAR; PAAL-KNORR SYNTHESIS; GUIDED DEVELOPMENT; MOLECULAR DOCKING; DUAL INHIBITORS; IN-VITRO; DERIVATIVES; DISCOVERY; DESIGN; POTENT; OSIMERTINIB;
D O I
10.1111/cbdd.14169
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The treatment of advanced non-small cell lung cancer (NSCLC) has made substantial progress due to the rapid development of small molecule targeted therapy, with dramatically prolonged survival. As an effective drug for the treatment of NSCLC, epidermal growth factor receptor (EGFR) inhibitors are currently experiencing issues like severe adverse events and drug resistance. It is urgent to develop novel types of EGFR inhibitors to overcome the abovementioned limitations. Pyrrole always works well as a probe for the creation of novel medication candidates for hard-to-treat conditions like lung cancer. Although the design, synthesis, and biological assays of pyrrole derivatives have been reported, their inhibitory actions against the receptor tyrosine kinase (RTK) EGFR have not been in-depthly studied. This review highlights the small molecule EGFR inhibitors containing pyrrole heterocyclic pharmacophores in recent years, and the research on their mechanism, biological activity, and structure-activity relationship (SAR).
引用
收藏
页码:195 / 217
页数:23
相关论文
共 72 条
[1]   INTERMEDIATES IN THE PAAL-KNORR SYNTHESIS OF PYRROLES [J].
AMARNATH, V ;
ANTHONY, DC ;
AMARNATH, K ;
VALENTINE, WM ;
WETTERAU, LA ;
GRAHAM, DG .
JOURNAL OF ORGANIC CHEMISTRY, 1991, 56 (24) :6924-6931
[2]   The discovery of a potent and selective third-generation EGFR kinase inhibitor as a therapy for EGFR L858R/T790M double mutant non-small cell lung cancer [J].
An, Baijiao ;
Pan, Tingting ;
Hu, Jinhui ;
Pang, Yanqing ;
Huang, Ling ;
Chan, Albert S. C. ;
Li, Xingshu ;
Yan, Jun .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 183
[3]  
André F, 2013, PHARMACOGENOMICS, V14, P931, DOI [10.2217/PGS.13.79, 10.2217/pgs.13.79]
[4]   Pemetrexed A Review of its Use in the Management of Advanced Non-Squamous Non-Small Cell Lung Cancer [J].
Baldwin, Claudine M. ;
Perry, Caroline M. .
DRUGS, 2009, 69 (16) :2279-2302
[5]   Straightforward highly efficient Paal-Knorr synthesis of pyrroles [J].
Banik, BK ;
Banik, I ;
Renteria, M ;
Dasgupta, SK .
TETRAHEDRON LETTERS, 2005, 46 (15) :2643-2645
[7]   Pyrrole: a resourceful small molecule in key medicinal hetero-aromatics [J].
Bhardwaj, Varun ;
Gumber, Divya ;
Abbot, Vikrant ;
Dhiman, Saurabh ;
Sharma, Poonam .
RSC ADVANCES, 2015, 5 (20) :15233-15266
[8]   Remarkable solvent effect in Barton-Zard pyrrole synthesis: application in an efficient one-step synthesis of pyrrole derivatives [J].
Bhattacharya, Apurba ;
Cherukuri, Sankara ;
Plata, Robert Erik ;
Patela, Nitinchandra ;
Tamez, Victoriano, Jr. ;
Grosso, John A. ;
Peddicord, Michael ;
Palaniswamy, Venkatapuram A. .
TETRAHEDRON LETTERS, 2006, 47 (31) :5481-5484
[9]   Synthesis and Anti-Proliferative Assessment of Triazolo-Thiadiazepine and Triazolo-Thiadiazine Scaffolds [J].
Boraei, Ahmed T. A. ;
Ghabbour, Hazem A. ;
Gomaa, Mohamed S. ;
El Ashry, El Sayed H. ;
Barakat, Assem .
MOLECULES, 2019, 24 (24)
[10]   Human hydroxymethylbilane synthase: Molecular dynamics of the pyrrole chain elongation identifies step-specific residues that cause AIP [J].
Bung, Navneet ;
Roy, Arijit ;
Chen, Brenden ;
Das, Dibyajyoti ;
Pradhan, Meenakshi ;
Yasuda, Makiko ;
New, Maria I. ;
Desnick, Robert J. ;
Bulusu, Gopalakrishnan .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (17) :E4071-E4080